Navin Fluorine to meet investors on Oct 12; Q1FY27 Revenue up 44% YoY
Navin Fluorine will interact with investors on October 12, 2026. In Q1 FY27, consolidated revenue rose 44% YoY to ₹1,045.1 crore, with EBITDA up 73% to ₹357.1 crore and PBT up 101% to ₹283.3 crore. Key segments like Specialty Chemicals and CDMO showed robust growth.
The significant year-on-year financial growth, particularly in revenue and profitability, coupled with strategic capex updates and new business vertical development, is expected to have a high impact on investor perception and the company's future outlook.
The company reported strong year-on-year growth in revenue, EBITDA, and PBT for Q1 FY27, alongside positive performance across its key business verticals. The upcoming investor meet also indicates proactive engagement with stakeholders.
Navin Fluorine International Limited announced that its officials will be interacting with Analysts/Investors on October 12, 2026. This interaction is scheduled to take place virtually with Goldman Sachs India for their 'Hidden Gems' series, involving both one-on-one and group meetings.
The company also reported its financial results for the first quarter of FY27 (ended June 30, 2026). Consolidated Net Revenue from Operations surged by 44% year-on-year to ₹1,045.1 crore, with an 11% increase quarter-on-quarter. Operating EBITDA grew by 73% year-on-year to ₹357.1 crore, and Operating PBT saw a significant increase of 101% year-on-year to ₹283.3 crore. The Operating EBITDA margin stood at 34.2%.
Key business verticals demonstrated strong performance. The High Performance Products (HPP) segment revenue increased by 33% to ₹357.1 crore, driven by volume and higher realisations, with pricing environment for HFC remaining constructive. The Specialty Chemicals segment reported a 48% revenue growth to ₹325 crore, underpinned by strong order visibility and a robust product pipeline. The Contract Development and Manufacturing Organisation (CDMO) business saw an impressive 82% revenue growth to ₹180 crore, supported by continued deeper engagement with a European CDMO major and an expanding order book.
Navin Fluorine is also progressing with its strategic capex plans. The additional HFC capacity of up to 15,000 MTPA of R32 is on track for commissioning by Q3 FY27. The Chemours project is targeted for completion by the end of Q2 FY27. De-bottlenecking of MPP capacity at Dahej is also expected by Q3 FY27. Furthermore, Phase II of the cGMP4 capex, amounting to ₹125 crore, is expected to operationalize by Q4 FY27. The company is also incubating a new business vertical in advanced materials, with a capex of ₹90 crore targeted for completion by Q2 FY28, focusing on niche applications in data centers, electronics, defence, and semiconductors.
An investment of ₹15.73 crore has been made in a Special Purpose Vehicle (SPV) for a 14.9 MW hybrid power plant, aiming to meet over 60% of energy needs from renewable sources.
What to do with a filing like this
Navin Fluorine International Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Navin Fluorine International Limited. Read the original for the full detail.